GlassScriptPhysician profile
Muhammad I Aslam
NPI 1720087711
$1,394.20
in general payments reported to CMS, 2019-2025
19 companies · $131 in 2025
The $131 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $180 · 2020: $173 · 2021: $309 · 2022: $155 · 2023: $296 · 2024: $150 · 2025: $131.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $577.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $577.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $230.80 | 2019-2025 | Jardiance |
| Astrazeneca Pharmaceuticals LP | $198.46 | 2019-2024 | Farxiga |
| Janssen Pharmaceuticals, INC | $153.39 | 2019-2023 | Xarelto |
| Abbott Laboratories | $146.27 | 2021 | |
| Cvrx, INC. | $102.66 | 2023-2025 | Barostim Neo System |
| Merck Sharp & Dohme LLC | $92.41 | 2021-2023 | Verquvo |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $67.92 | 2019-2025 | Lifevest |
| Amarin Pharma, INC. | $57.42 | 2020-2022 | |
| E.R. Squibb & Sons, L.L.C. | $56.22 | 2021-2023 | Camzyos |
| Amgen INC. | $40.53 | 2019-2023 | Repatha |
| Janssen Biotech, INC. | $35.00 | 2025 | Tremfya, Simponi Aria |
| Kestra Medical Technology Services, INC. | $34.32 | 2024 | Assure Wcd |
| Biotronik INC. | $31.26 | 2020 | |
| Boston Scientific Corporation | $30.87 | 2025 | Watchman Flx |
| Sanofi-Aventis U.S. LLC | $28.13 | 2020-2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novartis Pharmaceuticals Corporation | $26.80 | 2022 | |
| Pfizer INC. | $23.06 | 2023 | |
| Esperion Therapeutics, INC. | $19.75 | 2024 | Nexletol |
| Baxter Healthcare | $18.93 | 2023 | Hillrom - Cardiac Ambulatory Monitor |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Muhammad Aslam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.